World Market for Personalized Medicine Diagnostics (Biomarkers, Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing) | Market Research Reports | Market Research Report || Company Profile | announces, a new market research report is available in its vast collection:

World Market for Personalized Medicine Diagnostics (Biomarkers, Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing)


In this market research report, Kalorama Information defines the current opportunity and a realistic future potential for personalized medicine in clinical testing. In addition to analysis of tests currently on the market and in development, the report profiles key competitors and discusses trends that are important for understanding this much-discussed growth area of the diagnostic industry.

The concept of 'Personalized Medicine', as seen by Kalorama clinical diagnostics industry analyst Shara Rosen, is currently somewhere between dream and road to reality. Fantastic promises have been made over the years in the press and reports of startup concerns. However, slowly but surely real revenues are appearing, and realistic models for future growth will be seen.

Developments that are linked in the press to 'personalized medicine' are many, and can at times be confusing. But there are several discovered biomarkers that are important in diagnostic markets.

Biomarkers discussed in the report include:

Cytochrome P450 and Drug Metabolism
Estrogen Receptor and Progesterone
Receptor Status for Breast Cancer
HER2 Overexpression and Herceptin and Tykerb
Epidermal Growth Factor Receptor (EGFR)
KRAS Mutations and Anti-EGFR Therapy for Colorectal Cancer
BRAF Mutations and Cancer Therapy
UGT1A1 Genetic Variants
5-Flurouracil Therapy
PIK3CA Genetic Variation
KIF6 Genetic Variation
ALK Genetic Variation

This is a highly active market. A special focus of the report is the bustle of activity with collaborations between IVD and pharmaceutical companies, as well as IVD companies and CLIA labs. This report profiles scores of such companies operating in this market and estimates and forecasts markets (where there are products on the market) for personalized medicine technologies in the following categories:

Cardiac Markers, immunoassays
Cardiac Risk Markers
Cardiac markers, molecular
Coagulation, routine
Coagulation, molecular
Cancer, Tumor Markers
Cancer, Molecular
Cancer, Tissue-based
Psychiatric Disorders
Diabetes, BGM
Diabetes, HbA1c
Microbiology, ID/AST
Infectious Diseases, Viral Load (HIV, HCV, HBV)
Infectious Diseases, other
Blood Bank Molecular
Transplant Tissue Typing
Lab Developed Tests

More Related Reports :

  Cell Phone-Enabled Diagnostics: mHealth Applications in IVD

  Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional Pipeline Analysis to 2016

  Epigenomics, Present and Future Applications for Pharmaceuticals and Diagnostics

  Markets for Electrostimulation Devices (Neurostimulation, Cardiac Rhythm Management, Fracture Healing and Others)

  Medical Imaging Markets: Contrast Agents

  The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition

  What's Next In Vaccines (Malaria, Diabetes, Alzheimer's, Allergies and 30 Other Targets in the 2012-2021 Vaccine Pipeline)

  World Wound Care Markets (Skin Ulcer, Burns, Surgical/Trauma)

  The World Market for Veterinary Diagnostics

  The Market for Mobile Medical Apps

  Consumer Testing and The Future of DTC Genetic Testing

  The Global Market for Medical Devices, 3rd. Edition

  The World Market for Over The Counter (OTC) Drugs

RSS Link ...

For More details about above & other Reports plz contact :


Contact: Marketing team




You can also request for sample page of above mention reports on